A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kathy Miller, M.D.
Hoosier Oncology Group, Inc.
Principal Investigator - Robin T Zon, M.D.
Hoosier Oncology Group, Inc.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medical & Surgical Specialists, Llc
Galesburg, Illinois, United States
- Oncology Hematology Associates of Sw Indiana
Evansville, Indiana, United States
- Fort Wayne Oncology & Hematology, Inc
Fort Wayne, Indiana, United States
- Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
- Quality Cancer Center (mcgop)
Indianapolis, Indiana, United States
- Arnett Cancer Care
Lafayette, Indiana, United States
- Horizon Oncology Center
Lafayette, Indiana, United States
- Medical Consultants, P.C.
Muncie, Indiana, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- Ireland Cancer Center - University Hospitals of Cleveland
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2007
- Primary completion
- 31 Mar 2009
- Completion
- 31 Mar 2009
- Last update posted
- 14 Feb 2018
- Registered enrollment
- 18
- Registry id
- NCT00632541
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.